CS203003B2 - Process for preparing isocytosines - Google Patents

Process for preparing isocytosines Download PDF

Info

Publication number
CS203003B2
CS203003B2 CS766222A CS622276A CS203003B2 CS 203003 B2 CS203003 B2 CS 203003B2 CS 766222 A CS766222 A CS 766222A CS 622276 A CS622276 A CS 622276A CS 203003 B2 CS203003 B2 CS 203003B2
Authority
CS
Czechoslovakia
Prior art keywords
methyl
pyrimidone
ethanol
oxygen
phenyl
Prior art date
Application number
CS766222A
Other languages
Czech (cs)
English (en)
Inventor
Thomas H Brown
Graham J Durant
John C Emmett
Charon R Genellin
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of CS203003B2 publication Critical patent/CS203003B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CS766222A 1975-10-02 1976-09-27 Process for preparing isocytosines CS203003B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4034175 1975-10-02

Publications (1)

Publication Number Publication Date
CS203003B2 true CS203003B2 (en) 1981-02-27

Family

ID=10414412

Family Applications (1)

Application Number Title Priority Date Filing Date
CS766222A CS203003B2 (en) 1975-10-02 1976-09-27 Process for preparing isocytosines

Country Status (36)

Country Link
JP (2) JPS5246087A (ko)
AR (1) AR221682A1 (ko)
AT (1) AT358045B (ko)
AU (1) AU504897B2 (ko)
BE (1) BE846452A (ko)
BG (1) BG25224A3 (ko)
CA (1) CA1067076A (ko)
CH (1) CH625801A5 (ko)
CS (1) CS203003B2 (ko)
DD (1) DD126563A5 (ko)
DE (1) DE2643670C2 (ko)
DK (1) DK442476A (ko)
ES (1) ES452060A1 (ko)
FI (1) FI61701C (ko)
FR (1) FR2326192A1 (ko)
GR (1) GR61307B (ko)
HU (1) HU175537B (ko)
IE (1) IE44845B1 (ko)
IL (1) IL50503A (ko)
IN (1) IN146736B (ko)
IT (2) IT1070839B (ko)
LU (1) LU75922A1 (ko)
MW (1) MW3476A1 (ko)
MX (1) MX4614E (ko)
NL (1) NL7609917A (ko)
NO (1) NO145792C (ko)
NZ (1) NZ181959A (ko)
OA (1) OA05445A (ko)
PH (1) PH13921A (ko)
PL (1) PL105828B1 (ko)
PT (1) PT65590B (ko)
RO (1) RO73511A (ko)
SE (1) SE431872B (ko)
YU (1) YU237276A (ko)
ZA (1) ZA765498B (ko)
ZM (1) ZM12176A1 (ko)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MW5076A1 (en) * 1975-12-29 1978-02-08 Smith Kline French Lab Pharmacologicalle active compounds
NZ186511A (en) 1977-03-19 1980-11-14 Smith Kline French Lab 3-substituted alkylamino-6-substituted alkyl-1,2,4-triazin-5-ones and pharmaceutical compositions 3-substituted thio-1,2,4-triazin-5-ones
GR62452B (en) 1977-04-20 1979-04-12 Ici Ltd Preparation process of guanidine derivatives
US4165378A (en) 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
JPS54104816A (en) * 1978-01-27 1979-08-17 Memorex Corp Magnetic recorder tape reel
IN151188B (ko) * 1978-02-13 1983-03-05 Smith Kline French Lab
PH16240A (en) * 1978-04-11 1983-08-11 Smith Kline French Lab Process for making histamine antagonist
IL57416A (en) * 1978-05-30 1983-03-31 Smith Kline French Lab Nitro compounds,processes for preparing them and compositions containing them
ZA793443B (en) * 1978-07-26 1980-12-31 Glaxo Group Ltd Heterocyclic derivatives
US4374836A (en) 1978-10-16 1983-02-22 Imperial Chemical Industries Ltd. Antisecretory heterocyclic derivatives, process for their manufacture and pharmaceutical compositions containing them
US4496567A (en) * 1978-11-13 1985-01-29 Smith Kline & French Laboratories Limited Phenyl alkylaminopyrimidones
US4521418A (en) * 1979-02-21 1985-06-04 Smith Kline & French Laboratories Limited Guanidinothiazolyl derivatives
JPS55145683A (en) * 1979-04-26 1980-11-13 Smith Kline French Lab Pyrimidone derivative
CA1155842A (en) * 1980-03-29 1983-10-25 Thomas H. Brown Compounds
ZW21281A1 (en) * 1980-10-01 1981-11-18 Smith Kline French Lab Amine derivatives
IE53068B1 (en) * 1981-06-15 1988-05-25 Merck & Co Inc Diamino isothiazole-1-oxides and -1,1-dioxides as gastic secretion inhibitors
PT75074B (en) * 1981-06-27 1986-02-26 Smith Kline French Lab Process for preparing certain pyrimidone derivatives and compositions containing them
NZ202797A (en) * 1981-12-28 1985-08-30 Lilly Co Eli Pyrimidine derivatives and pharmaceutical compositions
JPS5993074A (ja) * 1982-10-01 1984-05-29 スミス・クライン・アンド・フレンチ・ラボラトリ−ス・リミテツド ピリミドン誘導体
DE8309239U1 (de) * 1983-03-29 1983-09-29 Basf Ag, 6700 Ludwigshafen Bandspule, insbesondere fuer magnetbaender

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1397436A (en) * 1972-09-05 1975-06-11 Smith Kline French Lab Heterocyclic n-cyanoguinidines
GB1419994A (en) * 1973-05-03 1976-01-07 Smith Kline French Lab Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them

Also Published As

Publication number Publication date
FI61701C (fi) 1982-09-10
FR2326192B1 (ko) 1979-01-12
JPS609755B2 (ja) 1985-03-12
PL105828B1 (pl) 1979-11-30
CH625801A5 (en) 1981-10-15
LU75922A1 (ko) 1977-05-06
NO145792B (no) 1982-02-22
AU504897B2 (en) 1979-11-01
NZ181959A (en) 1978-07-28
MX4614E (es) 1982-07-07
PT65590A (en) 1976-10-01
GR61307B (en) 1978-10-19
IE44845B1 (en) 1982-04-21
PT65590B (en) 1978-03-28
ZM12176A1 (en) 1977-07-21
IT1070839B (it) 1985-04-02
AR221682A1 (es) 1981-03-13
IL50503A0 (en) 1976-11-30
AT358045B (de) 1980-08-11
JPS5246087A (en) 1977-04-12
DD126563A5 (ko) 1977-07-27
CA1067076A (en) 1979-11-27
OA05445A (fr) 1981-03-31
SE431872B (sv) 1984-03-05
RO73511A (ro) 1981-04-30
FI762803A (ko) 1977-04-03
DE2643670C2 (de) 1982-07-01
YU237276A (en) 1983-01-21
IL50503A (en) 1980-12-31
JPS5695186A (en) 1981-08-01
ATA711976A (de) 1980-01-15
ES452060A1 (es) 1977-10-01
AU1829576A (en) 1978-04-06
ZA765498B (en) 1977-08-31
PH13921A (en) 1980-11-04
IE44845L (en) 1977-04-02
FR2326192A1 (fr) 1977-04-29
BG25224A3 (en) 1978-08-10
DE2643670A1 (de) 1977-04-14
BE846452A (fr) 1977-03-22
JPS5635674B2 (ko) 1981-08-19
SE7610409L (sv) 1977-04-03
NL7609917A (nl) 1977-04-05
NO145792C (no) 1982-06-02
NO763371L (ko) 1977-04-05
IN146736B (ko) 1979-08-25
FI61701B (fi) 1982-05-31
MW3476A1 (en) 1977-11-09
HU175537B (hu) 1980-08-28
IT7830708A0 (it) 1978-12-11
DK442476A (da) 1977-04-03

Similar Documents

Publication Publication Date Title
CS203003B2 (en) Process for preparing isocytosines
US6653320B2 (en) Imidazopyridine derivatives
EP1277754B1 (en) Imidazopyridine derivatives
JP5103403B2 (ja) ２−ピリミジニルピラゾロピリジンＥｒｂＢキナーゼ阻害剤
AU711438B2 (en) 7-amino-1H-indol derivatives
CA1090803A (en) 2-piperazinyl-6,7-dimethoxyquinazolines
US20100010025A1 (en) Pyrimidine Derivatives
JP2623800B2 (ja) チエノジアゼピン化合物
CN102203092A (zh) NPM-ALK、RET和BCR-ABL的α-咔啉抑制剂
CZ302359B6 (cs) Triazolové slouceniny a jejich použití
BG65180B1 (bg) Тиенопиридинови производни, полезни като противоракови средства
CZ290924B6 (cs) Aromatické sloučeniny, způsoby jejich přípravy a farmaceutické prostředky, které je obsahují
HUT77554A (hu) Tiazol- és tiadiazolszármazékok felhasználása dopamin-D3-receptor ligandumokat igénylő betegségek gyógyítására alkalmas gyógyszerkészítmények előállítására, valamint új származékok
JP2009023986A (ja) 抗癌剤としてのビアリール誘導体
JP2008266295A (ja) キナーセ゛阻害活性を有する新規チアシ゛アソ゛ール誘導体
CN105121443A (zh) 蛋白激酶抑制剂
KR20160067841A (ko) 헤테로사이클릭 화합물 및 사용 방법
CA2689607A1 (en) Kinase inhibitor compounds
EP0724572B1 (en) Fused tricyclic heteroaromatic derivatives as dopamine receptor subtype ligands
AU2016362394B2 (en) Heterocycle compounds and uses thereof
AP88A (en) Arylpiperazinyl-ethyl (orbutyl) - phenyl-heterocyclic compounds.
US7534805B2 (en) Imidazole derivatives, their preparation and their use as medicaments
CA2575771A1 (en) 5-ht7 receptor antagonists
EP4230204A1 (en) Thiobenzimidazole derivative or pharmaceutically acceptable salt thereof and use thereof
WO2019136093A1 (en) Inhibitors of low molecular weight protein tyrosine phosphatase (lmptp) and uses thereof